# OnCo record starpac2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/starpac2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "starpac2", "NCT04241276" ;
  schema:name "STARPAC2"@en ;
  schema:alternateName "STARPAC 2"@en, "STAR_PAC2"@en ;
  schema:description "STARPAC2 is a UK trial repurposing the vitamin A derivative used in leukaemia to soften the scar tissue around pancreatic tumours so chemotherapy works better; it follows a phase 1 (STAR_PAC) at Barts and has closed to recruitment with results due after 2028."@en ;
  schema:url <https://onco.cc/trials/starpac2/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04241276>, <https://www.isrctn.com/ISRCTN11503604> ;
  onco:status "active" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/locally-advanced-pdac/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/barts-cancer-institute/> ;
  onco:terms <https://onco.cc/terms/desmoplasia/>, <https://onco.cc/terms/pancreatic-trials-open-today/> .